Effect of whole-body 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma Academic Article uri icon

Overview

MeSH Major

  • Fluorodeoxyglucose F18
  • Lymphoma
  • Neoplasm Staging
  • Radiopharmaceuticals

abstract

  • This survey-based study of referring physicians indicates that FDG PET has a major impact on the management of lymphoma patients, contributing to changes in clinical stage in 44% and changes in treatment in >60% of cases.

publication date

  • August 16, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11483671

Additional Document Info

start page

  • 1139

end page

  • 43

volume

  • 42

number

  • 8